Cargando…
A Novel, Synthetic, Neuroactive Steroid Is Effective at Decreasing Depression-Like Behaviors and Improving Maternal Care in Preclinical Models of Postpartum Depression
Preclinical testing of treatments for postpartum depression (PPD) has been limited due to the lack of available animal models of such a complex disorder. To address this limitation, our laboratory has generated unique preclinical mouse models that exhibit abnormal postpartum behaviors. Mice with a l...
Autores principales: | Melón, Laverne, Hammond, Rebecca, Lewis, Mike, Maguire, Jamie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265503/ https://www.ncbi.nlm.nih.gov/pubmed/30532739 http://dx.doi.org/10.3389/fendo.2018.00703 |
Ejemplares similares
-
Neuroactive Steroids and GABAergic Involvement in the Neuroendocrine Dysfunction Associated With Major Depressive Disorder and Postpartum Depression
por: Maguire, Jamie
Publicado: (2019) -
Development of neuroactive steroids for the treatment of postpartum depression
por: Gunduz‐Bruce, Handan, et al.
Publicado: (2021) -
Role of Neuroactive Steroids in the Peripheral Nervous System
por: Melcangi, Roberto Cosimo, et al.
Publicado: (2011) -
Beyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and Emotion
por: Wirth, Michelle M.
Publicado: (2011) -
Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants
por: Kaufman, Yardana, et al.
Publicado: (2022)